NIM Norwood Imm.

RNS Number:1338K
Norwood Immunology Ld
09 October 2006


For immediate release                                            9 October 2006





                           NORWOOD IMMUNOLOGY LIMITED
                    ('Norwood Immunology' or 'the Company')


                    Resignation from the Board of Directors


Norwood Immunology Limited (AIM: NIM), the company focussed on the rejuvenation
of the immune system, today announces a resignation from its Board of Directors
with immediate effect.


Elizabeth Wyatt has tendered her resignation from the Board of the Company to
avoid what she has concluded are possible conflicts of interest given her other
responsibilities.


Richard Williams, CEO of Norwood Immunology, commented: "On behalf of the Board
I would like to thank Elizabeth for her contribution over the last year."


For further information please contact:


Norwood Immunology Limited                                    +44 (0)7860 295153
Richard Williams, Chief Executive Officer

Buchanan Communications                                      +44 (0)207 466 5000
Lisa Baderoon, Mark Court, Mary-Jane Johnson




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

BOAMFBPTMMBMBJF

Grafico Azioni Norwood Immunology (LSE:NIM)
Storico
Da Mag 2024 a Giu 2024

Grafico Azioni Norwood Immunology (LSE:NIM)
Storico
Da Giu 2023 a Giu 2024